Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2014 6
2015 2
2016 3
2018 1
2019 1
2020 6
2021 10
2022 4
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss.
Tóth EL, Orbán-Kálmándi R, Bagoly Z, Lóczi L, Deli T, Török O, Molnár S, Baráth S, Singh P, Hevessy Z, Katona É, Fagyas M, Szabó AÁ, Molnár S, Krasznai ZT. Tóth EL, et al. Among authors: fagyas m. Front Immunol. 2024 Feb 21;15:1329236. doi: 10.3389/fimmu.2024.1329236. eCollection 2024. Front Immunol. 2024. PMID: 38449857 Free PMC article.
Get reliable laboratory findings - how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?
Szabó AÁ, Enyedi EE, Altorjay IT, Hajnal P, Pintér TB, Mányiné IS, Váradi C, Bányai E, Tóth A, Papp Z, Fagyas M. Szabó AÁ, et al. Among authors: fagyas m. Clin Chem Lab Med. 2024 Jan 12. doi: 10.1515/cclm-2023-1288. Online ahead of print. Clin Chem Lab Med. 2024. PMID: 38205624 Free article.
Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis.
Kacsándi D, Fagyas M, Horváth Á, Végh E, Pusztai A, Czókolyová M, Soós B, Szabó AÁ, Hamar A, Pethő Z, Bodnár N, Kerekes G, Hodosi K, Szamosi S, Szűcs G, Papp Z, Szekanecz Z. Kacsándi D, et al. Among authors: fagyas m. Front Med (Lausanne). 2023 Oct 9;10:1226760. doi: 10.3389/fmed.2023.1226760. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37877017 Free PMC article.
Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients.
Tóth E, Fagyas M, Nagy B Jr, Siket IM, Szőke B, Mártha L, Mahdi M, Erdősi G, Pólik Z, Kappelmayer J, Papp Z, Borbély A, Szabó T, Balla J, Balla G, Bácsi A, Szekanecz Z, Bai P, Tóth A. Tóth E, et al. Among authors: fagyas m. Geroscience. 2024 Apr;46(2):1561-1574. doi: 10.1007/s11357-023-00887-2. Epub 2023 Sep 1. Geroscience. 2024. PMID: 37656328 Free PMC article.
The majority of severe COVID-19 patients develop anti-cardiac autoantibodies.
Fagyas M, Nagy B Jr, Ráduly AP, Mányiné IS, Mártha L, Erdősi G, Sipka S Jr, Enyedi E, Szabó AÁ, Pólik Z, Kappelmayer J, Papp Z, Borbély A, Szabó T, Balla J, Balla G, Bai P, Bácsi A, Tóth A. Fagyas M, et al. Geroscience. 2022 Oct;44(5):2347-2360. doi: 10.1007/s11357-022-00649-6. Epub 2022 Sep 16. Geroscience. 2022. PMID: 36112333 Free PMC article.
38 results